" class="no-js "lang="en-US"> Surge - Medtech Alert
Thursday, March 20, 2025
Surge | Pharmtech Focus

Surge

About Surge

Surge

Surge is a biotech company focused on optimizing treatment for patients undergoing surgery. Our multidisciplinary team has developed a test to identify patients at risk for complications. By anticipating surgical risks to enable personalization of the care pathway, this innovation will revolutionize the patient experience and shift the standard of surgical care. Our team shares a common vision for healthcare innovation: to develop patient-focused solutions that benefit the entire healthcare system.

Related Story

Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer

September 26 2022

Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated […]